Bortezomib

Key facts

Invented name
Velcade
Active substance
bortezomib
Therapeutic area
Oncology
Decision number
P/78/2008
PIP number
Bortezomib
Pharmaceutical form(s)
Powder of solution for injection
Condition(s) / indication(s)
Treatment of mantle cell lymphoma
Route(s) of administration
Intravenous use
Contact for public enquiries
Janssen-Cilag International NV

E-mail: sglawe@jacde.jnj.com
Country: Germany
Phone: +49 1737467682

Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating